Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0020852,
umls-concept:C0021745,
umls-concept:C0030705,
umls-concept:C0033268,
umls-concept:C0033684,
umls-concept:C0151332,
umls-concept:C0205369,
umls-concept:C0229671,
umls-concept:C0439851,
umls-concept:C0851287,
umls-concept:C1552596,
umls-concept:C1947931,
umls-concept:C1998793
|
pubmed:issue |
2
|
pubmed:dateCreated |
1988-3-18
|
pubmed:abstractText |
Twenty-one patients treated for active tuberculosis were examined for immune reactivity to purified protein derivative (PPD) and to a purified 32-kDa protein antigen (P32) from Mycobacterium bovis, strain BCG. Lymphoproliferation of peripheral blood leucocytes to PPD and P32 was positive in 95% and 71% of the patients respectively. A positive IFN-gamma response was detected in 62% against PPD and in 48% against P32. Low blastogenesis and IFN-gamma production were observed, especially in patients with poor general health and advanced tuberculous lesions. Twelve out of twelve (100%) of the tuberculin-positive healthy volunteers responded to PPD and P32 with mean lymphoproliferation and IFN-gamma values that were higher than in the patient group. Twelve tuberculin-negative control subjects were completely unreactive to PPD and P32 antigen. On the other hand, IgG antibodies in the serum were detected in 95% of the patients against PPD, in 77% of the patients against P32 but in none of the tuberculin-positive or negative healthy volunteers. The highest IgG levels against PPD were found in those patients with the lowest in vitro lymphoproliferation and IFN-gamma production (r = -0.54; P less than 0.05). Nonspecific interferon production following induction with Newcastle disease virus, Corynebacterium parvum, or phytohaemagglutinin was comparable in the control and patient groups. Finally, low IFN-alpha titres were detected in the serum of about 50% of the patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
187-94
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:3124263-Antigens, Bacterial,
pubmed-meshheading:3124263-BCG Vaccine,
pubmed-meshheading:3124263-Cell Division,
pubmed-meshheading:3124263-Humans,
pubmed-meshheading:3124263-Immunity, Cellular,
pubmed-meshheading:3124263-Immunoglobulin G,
pubmed-meshheading:3124263-Interferon-gamma,
pubmed-meshheading:3124263-Lymphocytes,
pubmed-meshheading:3124263-Mycobacterium bovis,
pubmed-meshheading:3124263-Tuberculin Test,
pubmed-meshheading:3124263-Tuberculosis, Pulmonary
|
pubmed:year |
1988
|
pubmed:articleTitle |
Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis.
|
pubmed:affiliation |
Instituut Pasteur van Brabant, Brussels, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|